Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II study

Bremer, BirgitAnastasiou, OlympiaHardtke, SvenjaCaruntu, Florin AlexandruCurescu, Manuela GabrielaYalcin, KendalAkarca, Ulus S.2024-04-242024-04-2420200168-82781600-0641https://hdl.handle.net/11468/23142[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Residual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II studyResidual low HDV viremia is associated with HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis D (delta): results from the HIDIT-II studyConference Object73S868S868WOS:000786587002509Q1